Abstract

Molecular and genomic surveillance systems for bacterial pathogens currently rely on tracking clonally evolving lineages. By contrast, plasmids are usually excluded or analyzed with low-resolution techniques, despite being the primary vectors of antibiotic resistance genes across many key pathogens. Here, we used a combination of long- and short-read sequence data of Klebsiella pneumoniae isolates (n = 1,717) from a European survey to perform an integrated, continent-wide study of chromosomal and plasmid diversity. This revealed three contrasting modes of dissemination used by carbapenemase genes, which confer resistance to last-line carbapenems. First, blaOXA-48-like genes have spread primarily via the single epidemic pOXA-48-like plasmid, which emerged recently in clinical settings and spread rapidly to numerous lineages. Second, blaVIM and blaNDM genes have spread via transient associations of many diverse plasmids with numerous lineages. Third, blaKPC genes have transmitted predominantly by stable association with one successful clonal lineage (ST258/512) yet have been mobilized among diverse plasmids within this lineage. We show that these plasmids, which include pKpQIL-like and IncX3 plasmids, have a long association (and are coevolving) with the lineage, although frequent recombination and rearrangement events between them have led to a complex array of mosaic plasmids carrying blaKPC Taken altogether, these results reveal the diverse trajectories of antibiotic resistance genes in clinical settings, summarized as using one plasmid/multiple lineages, multiple plasmids/multiple lineages, and multiple plasmids/one lineage. Our study provides a framework for the much needed incorporation of plasmid data into genomic surveillance systems, an essential step toward a more comprehensive understanding of resistance spread.

Highlights

  • Molecular and genomic surveillance systems for bacterial pathogens currently rely on tracking clonally evolving lineages

  • We show that carbapenemase genes, which confer resistance to last-line antibiotics, have spread in diverse ways including via one plasmid/multiple lineages, multiple plasmids/multiple lineages, and multiple plasmids/one lineage

  • Of 1,717 K. pneumoniae species complex isolates submitted during the European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE), we previously found that 249, 56, 79, and 312 carried blaOXA-48-like, blaVIM, blaNDM, and blaKPC genes, respectively [3]

Read more

Summary

Introduction

Molecular and genomic surveillance systems for bacterial pathogens currently rely on tracking clonally evolving lineages. We used a combination of long- and short-read sequence data of Klebsiella pneumoniae isolates (n = 1,717) from a European survey to perform an integrated, continent-wide study of chromosomal and plasmid diversity This revealed three contrasting modes of dissemination used by carbapenemase genes, which confer resistance to last-line carbapenems. The largest subset of CRE, the carbapenemase-producing Enterobacterales (CPE), hydrolyzes carbapenems and other beta-lactam antibiotics using diverse types of beta-lactamase enzymes called carbapenemases [3] Genes encoding these carbapenemases are usually located on plasmids, which can transmit vertically along clonal lineages as well as horizontally between different strains and species [4, 5]. These different trajectories must be considered in genomic surveillance systems and the design of new interventions

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.